Regulatory T Cells Move in When Gliomas Say "I DO"

被引：12
作者：
Choi, Bryan D. [1 ]
Fecci, Peter E. [2 ]
Sampson, John H. [1 ]
机构：
[1] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Duke Brain Tumor Immunotherapy Program, Div Neurosurg,Dept Surg,Med Ctr, Durham, NC 27710 USA
[2] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 22期
关键词：
BRAIN-TUMORS; CTLA-4; BLOCKADE; COMPARTMENT; SURVIVAL; IMMUNITY;
D O I：
10.1158/1078-0432.CCR-12-2801
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Indoleamine 2,3-dioxygenase (IDO) is an enzyme with known immunosuppressive and tolerogenic effects in cancer. Mounting evidence has associated IDO expression with the induction of regulatory T cells (Treg) and malignant progression. IDO inhibition may therefore provide a promising therapeutic approach for glioblastoma, where the need for novel treatment is great. Clin Cancer Res; 18(22); 6086-8. (C)2012 AACR.
引用
收藏
页码：6086 / 6088
页数：3
相关论文
共 12 条
  • [1] Site-specific anti-tumor immunity: Differences in DC function, TGF-β production and numbers of intratumoral Foxp3+ Treg
    Biollaz, Gregoire
    Bernasconi, Luca
    Cretton, Christine
    Puentener, Ursula
    Frei, Karl
    Fontana, Adriano
    Suter, Tobias
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (05) : 1323 - 1333
  • [2] An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
    El Andaloussi, Abdejabar
    Lesniak, Maciej S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (03) : 234 - 243
  • [3] Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors
    El Andaloussi, Abdeljabar
    Lesniak, Maciej S.
    [J]. JOURNAL OF NEUROSURGERY, 2006, 105 (03) : 430 - 437
  • [4] Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
    Fecci, PE
    Mitchell, DA
    Whitesides, JF
    Xie, WH
    Friedman, AH
    Archer, GE
    Herndon, JE
    Bigner, DD
    Dranoff, G
    Sampson, JH
    [J]. CANCER RESEARCH, 2006, 66 (06) : 3294 - 3302
  • [5] Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
    Fecci, Peter E.
    Ochiai, Hidenobu
    Mitchell, Duane A.
    Grossi, Peter M.
    Sweeney, Alison E.
    Archer, Gary E.
    Cummings, Thomas
    Allison, James P.
    Bigner, Darell D.
    Sampson, John H.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2158 - 2167
  • [6] Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells
    Fecci, Peter E.
    Sweeney, Alison E.
    Grossi, Peter M.
    Nair, Smita K.
    Learn, Christopher A.
    Mitchell, Duane A.
    Cui, Xiuyu
    Cummings, Thomas J.
    Bigner, Darell D.
    Gilboa, Eli
    Sampson, John H.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4294 - 4305
  • [7] CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
    Hodi, F. Stephen
    Oble, Darryl A.
    Drappatz, Jan
    Velazquez, Elsa F.
    Ramaiya, Nikhil
    Ramakrishna, Naren
    Day, Arthur L.
    Kruse, Andrea
    Mac Rae, Suzanne
    Hoos, Axel
    Mihm, Martin
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (09): : 557 - 561
  • [8] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
  • [9] Immunotherapy of malignant brain tumors
    Mitchell, Duane A.
    Fecci, Peter E.
    Sampson, John H.
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 222 : 70 - 100
  • [10] Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
    Mitchell, Duane A.
    Cui, Xiuyu
    Schmittling, Robert J.
    Sanchez-Perez, Luis
    Snyder, David J.
    Congdon, Kendra L.
    Archer, Gary E.
    Desjardins, Annick
    Friedman, Allan H.
    Friedman, Henry S.
    Herndon, James E., II
    McLendon, Roger E.
    Reardon, David A.
    Vredenburgh, James J.
    Bigner, Darell D.
    Sampson, John H.
    [J]. BLOOD, 2011, 118 (11) : 3003 - 3012
12